| Literature DB >> 35406634 |
Javad Mottaghipisheh1, Amir Hossein Doustimotlagh2,3, Cambyz Irajie4, Nader Tanideh5, Alireza Barzegar6,7, Aida Iraji5,8.
Abstract
As water-soluble flavonoid derivatives, anthocyanidins and anthocyanins are the plants pigments mostly rich in berries, pomegranate, grapes, and dark color fruits. Many bioactivity properties of these advantageous phytochemicals have been reported; among them, their significant abilities in the suppression of tumor cells are of the promising therapeutic features, which have recently attracted great attention. The prostate malignancy, is considered the 2nd fatal and the most distributed cancer type in men worldwide. The present study was designated to gather the preclinical and clinical studies evaluating potencies of anthocyanidins/anthocyanins for the treatment and prevention of this cancer type for the first time. In general, findings confirm that the anthocyanins (especifically cyanidin-3-O-glucoside) indicated higher activity against prostatic neoplasms compared to their correlated anthocyanidins (e.g., delphinidin); in which potent anti-inflammatory, apoptosis, and anti-proliferative activities were analyzed. Complementary anti-prostate cancer assessment of diverse naturally occurred anthocyanidins/anthocyanins and their synthetically optimized derivatives through preclinical experiments and eventually confirmed by clinical trials can promisingly lead to discover natural-based chemotherapeutic drug options.Entities:
Keywords: anthocyanidins; anthocyanins; apoptosis; cell cycle; cytotoxicity; prostate cancer
Mesh:
Substances:
Year: 2022 PMID: 35406634 PMCID: PMC8997497 DOI: 10.3390/cells11071070
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1The chemical structures of flavylium ion and its derivatives known as anthocyanidins.
Figure 2Schematic of some of the molecular pathways related to prostate cancer.
Figure 3The mechanism of actions of anthocyanidins/anthocyanins on the treatment of prostate cancer.
In vitro anti-tumor assessments of anthocyanidins/anthocyanins in pure forms and in plant rich extracts towards prostate cancer cells.
| Anthocyanin Source | Cell Line | Effect | Ref |
|---|---|---|---|
| Purple rice extract | LNCaP | Extract at 200 µg/mL significantly reduced the viability of prostate cancer cells after 48 h | [ |
| Muscadine grape skin extract | LNCaP | The extract decreased Snail and pSTAT3 expression and abrogated Snail-mediated CatL activity, migration, and invasion | [ |
| ARCaP-E | |||
| Brazilian native fruits, pitanga (red and purple) and araçá (yellow and red), as well as strawberry cultivars Albion, Aromas, and Camarosa, blackberry cultivar Tupy, and blueberry cultivar Bluegen | DU145 | No cytotoxicity was found | [ |
| LNCaP | Apoptotic rate (early and late) was statistically higher in tested cell lines exposed to | [ | |
| PC3 and DU-145 | Anchorage-dependent and anchorage-independent growth inhibition were seen | ||
| American cranberry | DU145 | 10, 25 and 50 µg/mL of the extract significantly decreased the cellular viability of DU145 cells. | [ |
| The extract at 25 and 50 µg/mL also lessened the proportion of cells in the G2-M phase of the cell cycle and increased the proportion of cells in the G1 phase after 6h in prostate carcinoma. | |||
| Red cabbage | DU145 | After 48 and 72 h 1, 2, 3, 4 and 5% juice reduced the proliferation of prostate cancer cell lines compared to the control group. | [ |
| LNCaP | |||
| Strawberries | LNCaP | Crude extracts (250 µg/mL) and pure compounds including C3G, pelargonidin, pelargonidin-3-glucoside, and pelargonidin-3-rutinoside (100 µg/mL) inhibited the growth of tested cancer cells significantly | [ |
| DU145 | |||
| Strawberry | P21 | The strawberry extract was cytotoxic with doses of ~5 μg/mL causing a 50% reduction in cell survival in both the normal and the tumor lines. | [ |
| P21 tumor cell line 1 and 2 | |||
| LNCaP | |||
| PC3 | |||
| Blue Maize ( | PC3 | PC3 treated with 5 mg/mL of acidified and non-acidified extracts demonstrated cell viability in the range of ~30 to 70% | [ |
| Blackberry ( | PC3 | Blackberry pulp and soursop pulp recorded cytotoxic effect with an IC50 of 1.81 ± 1.68% | [ |
| Sweet Cherry | PNT1A | The extract reduced the cell viability after 72 h at 2, 20, and 200 µg/mL compared to the control group MTT assay. | [ |
| LNCaP | |||
| PC3 | |||
| LNCaP.FGC | The fruit extract exhibited anticancer activity against LNCaP.FGC cells with an IC50 value of 34.09 mg/mL. | [ | |
| Pomegranate extract | LNCaP | 240 mL solution inhibited NF-κB and cell viability of prostate cancer cell lines in a dose-dependent fashion. | [ |
| LAPC4 | |||
| DU145 | |||
| Potato phenolics and their fractions | LNCaP | 5 mg chlorogenic acid eq/mL inhibited cell proliferation and increased the cyclin-dependent kinase inhibitor p27 levels in both LNCaP and PC3 cells. | [ |
| PC3 | |||
| Thai rice ( | PC3 | Thai rice showed cell viability with IC50 value of 167.8 ± 0.06 µM. | [ |
| Black carrots | PC3 | Cell viabilities were between 58 and 77% at a concentration of 100 μg/mL of extract. | [ |
|
| LNCaP | IC50 = 2.5 mg/mL against LNCaP cells viability. | [ |
| PC3 | |||
| DU145 | |||
| Lowbush blueberry | DU145 | Inhibition of MMP9 activity at 0.5 and 1.0 mg of crude fraction/mL was seen. Also, 1.0 mg/mL extract decreased the gelatinolytic activity of the activated isoforms of MMP-2 and complete inhibition of the pro-MMP-2, with an increase in TIMP-1 and TIMP-2 action. | [ |
| ( | |||
| Jaboticaba peel | PC3 | The non-polar extract was the most active agents against prostate cancer cells with GI50 = 13.8 μg/mL. | [ |
| Sweet potato ( | C4-2 | The extract significantly inhibited cell proliferation of all prostate cancer cells with IC50 values in the range of 145–315 µg/mL. IC50 of extract in normal prostate epithelial cells (PrEC and RWPE-1) was between 1000 and 1250 µg/mL. | [ |
| LNCaP | |||
| DU145 | |||
| C4-2B | |||
| PC3 | |||
| PrEC | |||
| RWPE-1 | |||
| Purple corn | LNCaP | Purple corn color at 50 and 100 ppm inhibited the proliferation of LNCaP cells by decreasing the expression of cyclin D1 and inhibiting the G1 stage of the cell cycle. | [ |
| LNCap | Cyanidin-3-O-(2″-O-xylosyl) glucoside showed potent anticancer effects with IC50 of 5.2 µg/mL | [ | |
| petunidin 3-O-[6-O-(4-O-(trans-p-coumaroyl)- α-L-rhamnopyranosyl)- β-D-glucopyranoside]-5-O-[ β-D-glucopyranoside] extracted from | DU145 | The IC50 viability of the compound against DU145 cells was about 361.58 µg/mL. The main anthocyanin monomer also inhibited cell proliferation, induced apoptosis, and promoted cell cycle arrest at the S phase. | [ |
| Cranberries | RWPE-1, RWPE-2, 22Rv1 | Total cranberry extract and all fractions (200 µg/mL) showed ≥50% antiproliferative activity against prostate cancer cells. Total polyphenols fraction as the most active one exhibited RWPE-1, 95%; RWPE-2, 95%; 22Rv1, 99.6% anti-proliferation potentials. | [ |
| C3G | DU145 | Compound produced significant anti-proliferative effects at 6 µM compared to the control group. Also, activation of caspase-3 and induction of p21 protein expression were seen at 50 and 100 µM. | [ |
| LnCap | |||
| Delphinidin | PC3 | Pure compound at 30–300 μM resulted in the induction of cyclin kinase inhibitors p21/WAF1 and p27/KIP1, down-regulation of cyclin E, D1, and D2, and cyclin-dependent kinase 2, 4, and 6. | [ |
ROS: reactive oxygen specie; C3G: cyanidin 3-O-glucoside.
Figure 4Chemical structure of cyanidin 3-O-glucoside.
Figure 5Chemical structure of cyanidin 3,5-diglucoside isolated from grape.
Figure 6Chemical structure of cyanidin-3-O-(6′’-acetyl-arabinoside), one the major compounds of red maize.
Figure 7The most potent antiproliferative agent identified in blue maize.
Figure 8The main compounds found in purple corn.
Figure 9Chemical structure of major compounds presented in strawberry.
Figure 10Chemical structure of cyanidin-3-O-(2″0-O-xylosyl)-glucoside.
Figure 11The extracted anthocyanin monomer from Lycium ruthenicum Murray namely petunidin 3-O-[6-O-(4-O-(trans-p-coumaroyl)-α-l-rhamnopyranosyl)-β-d-glucopyranoside]-5-O-[β-d-glucopyranoside].
Figure 12Chemical structure of delphinidin.
Animal studies evaluating the effects of pure anthocyanidins/anthocyanins and extracts rich in these compounds on prostate cancer.
| Applied Species | Diet | Supplement | Anthocyanin Dosage | Effect/Observation | References |
|---|---|---|---|---|---|
| Athymic (nu/nu) male nude mice | An autoclaved | Delphinidin | 2 mg/animal in 100 AL of 1:10 ratio of DMSO three times a week for 12 weeks | Reduced the expression of NF-κB/p65, Bcl-2, Ki67, and PCNA | [ |
| 12-week-old Sprague-Dawley male rats | A diet ad libitum | Anthocyanin extracted from black soybean | 40, 80, and 160 mg/kg of anthocyanin daily for 4 weeks | Decreased the volume and suppressing the proliferation of the prostate | [ |
| 6-week-old male nude mice | Normal diet | Polyphenol-rich sweet potato greens extract | 400 mg/kg polyphenol-rich sweet potato greens extract daily for 6 weeks | Inhibited growth and progression of prostate tumor xenografts by 69% in nude mice | [ |
| 12-week-old male Sprague-Dawley rats | n.d | Anthocyanin extracted from the seed coat of the black soybean | 160 mg/kg of anthocyanin daily for 8 weeks | Prevented the rapid prostatic cell death by apoptosis in the prostate in an animal model of andropause | [ |
| 7-week-old male Kunming mice | Standard diet | Anthocyanin extract from bilberry | 200 mg/kg of anthocyanins extract from bilberry | Enhanced the therapeutic effect of Pollen of | [ |
| Male Sprague-Dawley rats | Anthocyanin extracted from black soybean | 50 mg/kg of anthocyanin extracted from black soybean twice a day for 2 weeks | Showed the anti-inflammatory and antimicrobial effects, as well as the synergistic effect with | [ | |
| 16-week-old Sprague Dawley male rats | Seoritae extract including isoflavone and anthocyanin | 228 and 457 mg/kg of seoritae extract in 1 mL distilled water daily for 5 weeks | Reduced the prostate weight, oxidative stress, apoptosis, and 5α-reductase activity | [ | |
| 6-week-old male BALB/c nude mice | Anthocyanin from black soybean | 8 mg/kg of anthocyanin dissolved in 1 mL of distilled water daily for 14 weeks | Inhibited the progression of prostate cancer in a xenograft model. | [ | |
| 8-week-old male Sprague–Dawley rats | Standard laboratory diet | Polymerized anthocyanin from | 100 mg/kg of polymerized anthocyanin from polymerized anthocyanin daily for 4 weeks | Reduced the prostate weight in rats with testosterone propionate–induced BPH, decreased the AR, 5AR2, SRC1, PSA, PCNA, and cyclin D1 expression in prostate tissues, ameliorated the BPH-mediated increase of Bcl-2 expression, and increased the Bax expression. | [ |
| 7-week-old male Wistar rats | A diet ad libitum | 100 mg/kg of | Attenuated the development of testosterone-induced prostatic hyperplasia | [ | |
| Male FVB mice | Standard diet | Brazilian berry extract ( | 2.9 and 5.8 g/kg of jaboticaba peel extract daily for 60 days | Exerted a dose-dependent effect controlling inflammation and oxidative-stress in aging and high-fat diet-fed aging mice prostate | [ |
| Male heterozygous TRAP rats | A diet ad libitum | Anthocyanin-rich fraction from purple rice | 0.2 or 1% of hexane insoluble fraction from a purple rice ethanolic extract daily for 10 weeks | Retarded carcinogenesis and castration-resistant cancer growth of prostate through suppression of androgen receptor mediated cell proliferation and metabolism | [ |
C3G: Cyanidin 3-O-glucoside, n.d: not determined, TRAP: transgenic rat for adenocarcinoma of prostate, BPH: benign prostatic hyperplasia.
Clinical trials evaluating the efficacy of anthocyanins on prostate cancer patients.
| Population | Number of Populations + Age Range | Study Type | Diet | Source of Anthocyanin | Anthocyanin Daily Dose | Association between Anthocyanin Intake and CRC Risk | Reference |
|---|---|---|---|---|---|---|---|
| Patients newly diagnosed with resectable prostate cancer | 56 men/average age: 61.6 ± 1.02 years | Interventional | n.d | Nectar of BRB | 10 g BRB/day (8 men): 10 g BRB in 1 bottle | n.a | [ |
| Nectar of BRB | 20 g BRB/day (8 men): 20 g BRB in 1 bottle | ||||||
| Confection of BRB | 10 g BRB/day (8 men): 10 g BRB in 5 pieces (total: 1600 pieces) | ||||||
| Confection of BRB | 20 g BRB/day (8 men): 20 g BRB in 10 pieces (total: 3200 pieces) | ||||||
| Patients receiving image guided intensity modulated radiation | 41 men/average age: 68 years | Observational | Mostly New Zealand | cranberry ( | 1 capsule/day at breakfast during radiation therapy treatment, and | 65% of patients taking cranberry capsules developed cystitis compared to the placebo group (90% patients) | [ |
| 30% of patients taking cranberry capsules | |||||||
| Patients receiving external beam radiation therapy to their prostate bed or prostate only and had not received previous pelvic radiation therapy | 101 men/average age: 68 years (range 51–85) | Observational | Mostly New Zealand | cranberry ( | 2 capsules at breakfast during radiation therapy treatment, | Three measurements of cystitis severity: | [ |
BRB: black raspberry (Rubus occidentalis), R TOG: radiation therapy oncology group grading, RICAS: novel radiation induced cystitis assessment scale, na: not analysed, n.d: not determined.